An observational study in Obstructive Sleep Apnea (OSA) and Polysomnography, sponsored by Fu Jen Catholic University. Completed at 1 site in Taiwan. Open to participants aged 30 Years to 75 Years. Per ClinicalTrials.gov, last updated 2026-11-10.
Sponsored by Fu Jen Catholic University · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 90 studies in Sleep Apnea, Obstructive with a site in Taiwan — 26 open to participants now, 27 under way, 3 of them phase 3. Sleep Apnea, Obstructive · Taiwan.
Among the 90 studies in Sleep Apnea, Obstructive with a site in Taiwan, this one is the 11th largest by enrollment of the 32 observational ones that give a count, is one of 8 that started in 2025, is one of 32 observational ones, and was the 81st registered.
2,246 studies on the registry are indexed under Sleep Apnea, Obstructive; 476 are open to participants now.
Browse Sleep Apnea, Obstructive studies →26 of the 90 studies in Sleep Apnea, Obstructive with a site in Taiwan are open now. Recruiting first, the newest first:
Fu Jen Catholic University · Sites in Taiwan
Ages 4–18
National Sun Yat-sen University · Sites in Taiwan
Ages 20–80
National Sun Yat-sen University · Sites in Taiwan
Ages 20+
Novo Nordisk A/S · Sites in Taiwan, United States, Australia and 7 more countries
Ages 18+
Novo Nordisk A/S · Sites in Taiwan, United States, Australia and 7 more countries
Ages 18+
A study can be open while its sites in Taiwan have not opened yet or have stopped. Only those recruiting at a site in Taiwan →
Of the 317 Sleep Apnea, Obstructive studies recruiting now, 149 (47%) set no upper age limit and 124 (39%) stop at 75 or younger; 53 take children under 18; 66 take healthy volunteers.
This study: 30 Years to 75 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
90 studies; the count open now beside each. This study's row is marked.
First in 2005; this study’s year is marked. 8 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 150 is above the median of 105 across 668 observational studies indexed under Sleep Apnea, Obstructive.
Median enrollment 71 across the 58 interventional studies, 103 across the 32 observational. Of the 38 that completed or were terminated, 4 (11%) have results posted.
This tab as a report to print or save as PDF → With an account.
11 of 90 have an industry lead sponsor. The 10 most frequent:
Fu Jen Catholic University is the lead sponsor of 48 studies on the registry; 22 are open to participants now.
Fu Jen Catholic University has 3 studies filed under Sleep Apnea, Obstructive — fewer than ten, so there is no comparison to draw.
6 of the studies in Sleep Apnea, Obstructive with a site in Taiwan that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06854497Chiayi Christian HospitalThe Impact of Non-motor Symptom on the Outcome of Stroke Subjects | 2026-12-31 |
| NCT06115018Yi-Ju, LaiThe Efficacy and Maintain Effect of OPR on OSA Patients After Palatal Surgery | 2026-12-31 |
| NCT07603583Kaohsiung Armed Forces General HospitalAssessment of Heart Rate Variability for Predicting Obstructive Sleep Apnea in Patients With Hypertension | 2026-12-31 |
| NCT07192042Taipei Medical University Shuang Ho HospitalInvestigation of Using Non-Wearable Devices to Assess Sleep- Disordered Breathing in Hospitalized Patients With Schizophrenia | 2027-04-30 |
| NCT07805486Fu Jen Catholic UniversityDevelopment of a Multimodal Deep Learning Model for Pediatric Patients | 2027-07-31 |
Add all 6 to your calendar (.ics) → With an account.
Among the 90 studies in Sleep Apnea, Obstructive with a site in Taiwan, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This study aims to develop a multimodal deep learning model that integrates noninvasive signals to predict the severity of obstructive sleep apnea. By establishing a clinically viable and user-friendly monitoring tool, the study seeks to enhance early screening accessibility and support the development of home-based sleep care systems.
Obstructive sleep apnea is a common sleep disorder closely associated with cardiovascular, metabolic, and neuropsychiatric comorbidities. It is characterized by repeated upper airway collapse during sleep, leading to intermittent hypoxia and sleep fragmentation. Although polysomnography remains the diagnostic gold standard for obstructive sleep apnea, its high cost, complexity, and limited accessibility pose challenges for large-scale screening and early identification. Recent advancements in noninvasive sensing technologies-such as electronic stethoscopes, wearable oximeters, and under-mattress pressure sensors-have enabled low-burden physiological monitoring solutions, offering new opportunities for simplified obstructive sleep apnea detection. In this study, synchronized multimodal physiological data will be collected during overnight sleep, including respiratory sounds, continuous saturation measurements, and standard polysomnography waveforms. Signal preprocessing and feature extraction will be performed to ensure data quality and temporal alignment. A deep learning model will be developed using these multimodal signals as inputs. The apnea-hypopnea index will be derived from overnight polysomnography. The model will be trained to estimate apnea-hypopnea index values and classify obstructive sleep apnea severity according to established clinical thresholds.
patient of Affiliated University Hospital
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
digital device amplifying and recording cardiopulmonary sounds
a small device placed on the finger to measure blood oxygen saturation (SpO₂) and pulse rate noninvasively.
using ballistocardiography (BCG) for monitoring respiration and heart rate
apnea-hypopnea index, sound waveforms, and the correlation between apnea-hypopnea index and ballistocardiography waveforms
Time frame: one night
Plan to share: No
No publications or documents are linked to this record.
Ran from Sep 2025 to primary completion in Aug 2026, 11 months.
Of 258 non-industry observational studies under Sleep Apnea, Obstructive, half reached primary completion within 31 months of starting (the median), counting those still running; a quarter within 16 and three quarters within 63. This study's 11 months is below that.
Counting every sponsor, half of 294 studies reached it within 29 months; a quarter within 14 and three quarters within 63.
Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 10, 2026: primary completion Jul 2026 → Aug 2026 and completion Jul 2026 → Aug 2026.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is completed, as verified in Feb 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Fu Jen Catholic University